Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300357.SZ

HOLD

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. · Healthcare · China · $1.6B · Avg Vol: $34M/d

61
StockRank
Get insider-trade alerts
Q
82
V
26
M
46
P/E (TTM)
29.4x
ROE
15.4%
D/E
0.0x
Dividend %
1.1%
Dir. Trades · 180d
None →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the development and commercialization of allergen immunotherapy products. The company holds a near-monopoly position in China's sublingual immunotherapy (SLIT) market with its flagship dust mite drops. Its strong clinical reputation, extensive hospital sales network, and high regulatory barriers for biological products establish a highly defensive competitive moat.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue132.0M124.9M136.3M156.5M5.8%160.1M177.3M212.7M16.6%
EPS0.100.090.090.113.0%0.120.130.1519.5%
Shares523.6M523.6M523.6M523.6M0.0%523.6M———
Debt2.4M9.2M3.8M2.7M4.2%2.9M———
Equity291.6M321.8M346.7M385.8M9.8%————
Op CF53.1M56.3M38.7M62.3M5.5%57.8M———
Inv CF-17.4M-28.3M-87.7M-40.0M—————
Fin CF-16.4M-3.4M-21.6M-19.0M—————
Loading 1Y...
PRICE (1Y)+4.8%
3.063.193.333.463.59May 29Jun 22Jul 10
SMA 50SMA 200
Close
$3.48
RSI (14)
60.1
52W High
$5.23
From 52W High
0.7%

SCORE BREAKDOWN

Quality
82
ROIC
15.7%86.4
ROE
15.4%83.7
GP/Assets
35.8%75.2
Op. Margin
38.3%96.3
FCF/Assets
2.2%55.0
Piotroski
893.4
Int. Cover
50.0x88.5
D/E Ratio
0.01x91.1
Current Ratio
26.14x97.2
Value
26
P/E (TTM)
29.4x38.8
EV/EBITDA
22.7x26.1
P/FCF
172.8x7.7
P/B
4.5x30.2
P/S
11.5x24.6
Div Yield
1.1%27.3
Momentum
46
52W High %
67%45.9
RS 6M
-19%47.8
SMA 50/200
0.84x24.4
EPS Rev 4W
-0.3%38.9
EPS Rev 12W
—N/A
EPS Improve
+26%36.9
Q Growth
60%79.1

FUNDAMENTALS

Market Cap
$1.6B
P/E (Forward)
23.3x
Gross Margin
95.3%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300357.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300357.SZZhejiang Wolwo Bio-Pharmaceutical Co., Ltd.(you)$1.6B61HOLD
688710.SSShanghai InnoStar Bio-tech Co., Ltd.$1.3B62HOLD
002019.SZYifan Pharmaceutical Co., Ltd.$1.7B38HOLD
600771.SSGuangYuYuan Chinese Herbal Medicine Co., Ltd.$916M48HOLD
600713.SSNanjing Pharmaceutical Group Company Limited$977M77BUY
300181.SZZhejiang Jolly Pharmaceutical Co.,LTD$1.3B85STRONG BUY
301507.SZHangzhou Minsheng Healthcare Co., Ltd.$633M44HOLD
600666.SSAurora Optoelectronics Co.,Ltd.$1.7B25SELL
002422.SZSichuan Kelun Pharmaceutical Co., Ltd.$8.3B66BUY
000411.SZZhejiang Int'l Group Co.,Ltd.$749M83STRONG BUY

Peer medians: ROE 4.7% · P/E 28.4x · Gross margin 52.5%

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) — Stock Score Summary

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) has a MoatMap StockRank of 61/100 based on Quality (82/100), Value (26/100), and Momentum (46/100) factor scores. The current signal is HOLD.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the development and commercialization of allergen immunotherapy products. The company holds a near-monopoly position in China's sublingual immunotherapy (SLIT) market with its flagship dust mite drops. Its strong clinical reputation, extensive hospital sales network, and high regulatory barriers for biological products establish a highly defensive competitive moat.

Key Financial Metrics

Price$3.48
Market Cap$1.6B
P/E (TTM)29.36
P/E (Forward)23.31
Price/Book4.55
Return on Equity15.4%
Return on Invested Capital15.7%
Debt/Equity0.69
Gross Margin95.3%
Operating Margin38.3%
Revenue Growth10.7%
Dividend Yield1.1%
Free Cash Flow$10M

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - General industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.’s (300357.SZ) StockRank?
MoatMap’s StockRank for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) is 61/100, with a Hold signal. It is a composite of Quality (82), Value (26), and Momentum (46) factor ranks across MoatMap’s 20,000+ stock universe.
Does Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. have an economic moat?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) has a Quality factor score of 82/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) is Hold, based on a StockRank of 61/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. in?
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - General industry (China).
Browse all ranked stocks300357.SZ deep dive reportAI ChampionsHow we score stocksSense-check another stock